Tanvex BioPharma, Inc. 6541.TW Stock
Tanvex BioPharma, Inc. Price Chart
Tanvex BioPharma, Inc. 6541.TW Financial and Trading Overview
| Tanvex BioPharma, Inc. stock price | 48 TWD |
| Previous Close | 75.6 TWD |
| Open | 73.8 TWD |
| Bid | 74.4 TWD x 0 |
| Ask | 76.2 TWD x 0 |
| Day's Range | 73.8 - 77.1 TWD |
| 52 Week Range | 73.8 - 219.74 TWD |
| Volume | 1.15M TWD |
| Avg. Volume | 176.44K TWD |
| Market Cap | 9.94B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -16.42 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6541.TW Valuation Measures
| Enterprise Value | 8.89B TWD |
| Trailing P/E | N/A |
| Forward P/E | -19.89305 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.290159 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Tanvex BioPharma, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -61.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 219.74 TWD |
| 52 Week Low | 73.8 TWD |
| 50-Day Moving Average | 79.76 TWD |
| 200-Day Moving Average | 106.99 TWD |
6541.TW Share Statistics
| Avg. Volume (3 month) | 176.44K TWD |
| Avg. Daily Volume (10-Days) | 77.24K TWD |
| Shares Outstanding | 133.67M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 47.30% |
| % Held by Institutions | 3.54% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 333.57715:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.19 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -19348000 TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -15.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 11.828 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Tanvex BioPharma, Inc.
| Country | Taiwan |
| State | N/A |
| City | George Town |
| Address | 802 West Bay Road |
| ZIP | KY1-1205 |
| Phone | N/A |
| Website | https://www.tanvex.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
Q&A For Tanvex BioPharma, Inc. Stock
What is a current 6541.TW stock price?
Tanvex BioPharma, Inc. 6541.TW stock price today per share is 48 TWD.
How to purchase Tanvex BioPharma, Inc. stock?
You can buy 6541.TW shares on the Taiwan exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tanvex BioPharma, Inc.?
The stock symbol or ticker of Tanvex BioPharma, Inc. is 6541.TW.
Which industry does the Tanvex BioPharma, Inc. company belong to?
The Tanvex BioPharma, Inc. industry is Biotechnology.
How many shares does Tanvex BioPharma, Inc. have in circulation?
The max supply of Tanvex BioPharma, Inc. shares is 135.25M.
What is Tanvex BioPharma, Inc. Price to Earnings Ratio (PE Ratio)?
Tanvex BioPharma, Inc. PE Ratio is now.
What was Tanvex BioPharma, Inc. earnings per share over the trailing 12 months (TTM)?
Tanvex BioPharma, Inc. EPS is -16.42 TWD over the trailing 12 months.
Which sector does the Tanvex BioPharma, Inc. company belong to?
The Tanvex BioPharma, Inc. sector is Healthcare.
Tanvex BioPharma, Inc. 6541.TW included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}